OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada... Show more
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where OGI declined for three days, in of 325 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OGI as a result. In of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Aroon Indicator for OGI entered a downward trend on April 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where OGI's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for OGI just turned positive on March 17, 2025. Looking at past instances where OGI's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OGI advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .
OGI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.011) is normal, around the industry mean (60.901). P/E Ratio (0.000) is within average values for comparable stocks, (90.174). OGI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (1.384) is also within normal values, averaging (20.092).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OGI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OGI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
a company, which, engages in the production and sale of medical marijuana
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, OGI has been closely correlated with SNDL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then SNDL could also see price increases.
Ticker / NAME | Correlation To OGI | 1D Price Change % | ||
---|---|---|---|---|
OGI | 100% | -4.79% | ||
SNDL - OGI | 67% Closely correlated | -1.74% | ||
CRON - OGI | 63% Loosely correlated | -1.66% | ||
TLRY - OGI | 62% Loosely correlated | -5.17% | ||
CGC - OGI | 57% Loosely correlated | -10.19% | ||
ACB - OGI | 52% Loosely correlated | -4.14% | ||
More |
Ticker / NAME | Correlation To OGI | 1D Price Change % |
---|---|---|
OGI | 100% | -4.79% |
OGI (2 stocks) | 91% Closely correlated | -3.22% |
north america (189 stocks) | 45% Loosely correlated | -3.42% |
Pharmaceuticals (304 stocks) | 20% Poorly correlated | -1.86% |
Pharmaceuticals: Other (213 stocks) | 12% Poorly correlated | -2.55% |